Skip Navigation

FDA’s new regulations underscore the complexity around screening for women with dense breasts.

theconversation.com FDA’s new regulations underscore the complexity around screening for women with dense breasts

The FDA’s rule change requires that all women in the US be informed about breast density and options for supplemental screening.

FDA’s new regulations underscore the complexity around screening for women with dense breasts
1
1 comments